| 英文别名： |
Cyclohexanaminium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogendiphosphate;ADENOSINE 5’-DIPHOSPHATE DI(MONOCYCLOHEXYLAMMONIUM) SALT;Adenosine 5'-diphosphate bis(cyclohexylammonium) salt;ADENOSINE 5'-DIPHOSPHATE DI(MONOCYCLOHEXYLAMMONIUM) SALT;Adenosine 5'-diphosphate di(dicyclohexyl)amine salt;ADP;methyl hydrogendiphosphate;Cyclohexanaminium ((2R,3S,4R,5R);ADP DI(MONOCYCLOHEXYLAMMONIUM) SALT;Adenosine 5`-diphosphate di(dicyclohexyl)aMine salt;ADENOSINE 5'-DIPHOSPHATEDI(MONOCYCLOHEXY LAMMONIUM);Adenosine 5′-diphosphate bis(cyclohexylammonium) salt,ADP;Adenosine 5'-(trihydrogen diphosphate) cyclohexanamine salt;Cyclohexanaminium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)m;[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate;;adenosine 5'-diphosphate bis(cyclohexylammonium) salt;Adenosine 5′-Diphosphate bis(Cyclohexylammonium) Salt;ADP (cyclohexanamine);Adenosine 5'-diphosphate bis(cyclohexylammonium) salt, >=95% (HPLC), crystalline, bacterial;Cyclohexanaminium ((2R pound not3S pound not4R pound not5R)-5-(6-amino-9H-purin-9-yl)-3 pound not4-dihydroxytetrahydrofuran-2-yl)methyl hydrogendiphosphate;C71098;Adp Di(monocyclohexylammonium) salt;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate;cyclohexanamine;AC-37053;ADENOSINE 5/'-DIPHOSPHATE DI(MONOCYCLOHEXYLAMMONIUM) SALT;102029-87-8;Adenosine 5'-diphosphate di(monocyclohexylammonium)salt;MFCD00058338;cyclohexanamine hemi(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate) |
沪公网安备31011402010658号 
(%5bH%5d)%5bC%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bC%40%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bH%5d)
